|
Gene Therapy for Mutations in the IQSEC2 Gene
Learn about current research and the potential of gene replacement therapy in boys with IQSEC2 premature termination variants.
Prof. Andrew Levy
Technion Israel Institute of Technology
|
Wednesday, March 18th
3 p.m. Eastern Time (U.S.)
This is a joint presentation with the World Autism Organisation.
|